Target
Corporate Bias Rating
Expand Summary
Risk Level:
Summary:
Target is High Risk. The company yields to political activism in shaping corporate governance, potentially alienating consumers, dividing employees, and harming shareholders. The company implements race and identity-based policies that replace merit, excellence, and integrity with preferential treatment and outcomes. Target embraces corporate initiatives that redirect its central focus from business goals to partisan policies and divisive issues. This approach fails to safeguard free exercise, free speech, and free enterprise.
View Full Corporate Bias Ratings ReportBoard Bias
Expand Summary
CEO of Target
Brian C. Cornell
Summary:
Headquartered in Minneapolis, Minnesota, Target is a member of the Fortune 250 operating in the Retailing industry. Brian C. Cornell and Brian C. Cornell serve as CEO/President and Chairman, respectively, leading the company’s C-suite executive team and the board of directors. Amongst these teams, the collective leadership is responsible for $138,100 to Republican causes and $288,675 to Democratic causes. Under their tenure, Target currently holds a 'High Risk' risk rating.
View Full Board Bias ReportPolitical Contributions of Leadership:
$138,100
$288,675
Republican
Democrat
China Risk Database
Expand Summary
Total Estimated Sanctions (3-year Avg.)
$445,892
Average Annual Revenue
Global
$85,610,333,333
China Revenue
0.00%
$0
Annual Average of Total Assets
Global
$45,631,000,000
China Assets
0.00%
$400,000
Shareholder Proposals
Expand Summary
| Date | ESG Category | Proponent | Summary of Resolution | Mgmt Rec | Total Vote % in Favor |
|---|---|---|---|---|---|
| 6/12/24 | Governance | The Accountability Board | Independent Board Chair | Against | 28.98% |
| 6/12/24 | Social | The Humane Society | Shareholder Proposal Requesting Animal Pain Management Reporting | Against | 9.34% |
| 6/12/24 | Social | Legal & General Investment Management America | Set Compensation Policy That Optimizes Portfolio Value for Company Shareholders | Against | 12.65% |
| 6/12/24 | Governance | Tara Health Foundation | Political Expenditures Misalignment with Company Values | Against | 14.42% |
| 6/12/24 | Governance | National Center for Public Policy Research | Financial Sustainability and Risk Report | Against | 2.17% |
| 6/14/23 | Governance | John Chevedden | Independent Board Chairman | Against | 32.10% |
| 6/8/22 | Governance | John Chevedden | Proxy Access Amendments | Against | 36.00% |
In the News
Expand Summary